Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million.

Privacy concerns related to customers’ genetic information have also emerged, notably spanning from a 2023 data breach — along with questions around what new ownership could mean for users’ data.